Morgens Waterfall Vintiadis & Co’s Cellectis CLLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-17,000
Closed -$291K 36
2019
Q4
$291K Hold
17,000
0.2% 50
2019
Q3
$177K Hold
17,000
0.14% 51
2019
Q2
$265K Sell
17,000
-16,000
-48% -$286K 0.18% 55
2019
Q1
$605K Buy
33,000
+16,000
+94% +$284K 0.43% 43
2018
Q4
$283K Hold
17,000
0.25% 59
2018
Q3
$480K Hold
17,000
0.31% 53
2018
Q2
$481K Hold
17,000
0.34% 51
2018
Q1
$536K Buy
+17,000
New +$537K 0.41% 47
2017
Q4
Sell
-17,600
Closed -$501K 60
2017
Q3
$501K Buy
+17,600
New +$455K 0.42% 41

Other funds holding CLLS

Morgens Waterfall Vintiadis & Co's CLLS Position: Q1 2020 in Review

Morgens Waterfall Vintiadis & Co sold out of Cellectis (CLLS) in Q1 2020, closing a stake of 17,000 shares — an estimated $291K sold.

Morgens Waterfall Vintiadis & Co first reported a position in CLLS in Q3 2017 and held it in 9 quarters. The position peaked at $605K in Q1 2019. 66 funds tracked by Wall St. Rank hold CLLS as of Q1 2020.

  • Morgens Waterfall Vintiadis & Co reported no remaining Cellectis position as of Q1 2020 after selling out during the quarter.
  • Morgens Waterfall Vintiadis & Co sold 17,000 Cellectis shares in Q1 2020, an estimated $291K.
  • Morgens Waterfall Vintiadis & Co first reported a position in Cellectis in Q3 2017 and held it in 9 quarters.
  • Morgens Waterfall Vintiadis & Co's Cellectis position peaked at $605K in Q1 2019.
  • 66 funds tracked by Wall St. Rank held Cellectis as of Q1 2020.

Based on Morgens Waterfall Vintiadis & Co's 13F filing for Q1 2020, filed 15 May 2020.